KAREN MILLETT: Open Payments
NPI 1134378334 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$127 in 7 payments from 6 companies in 2025. Trend: 2023 $318 · 2024 $202 · 2025 $127
Food & beverage: $127
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Tris Pharma Inc | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: COBENFY, REXULTI, SPRAVATO, Dyanavel XR, ARISTADA, CAPLYTA.
Industry payments across UT — which companies pay providers there.
